Cargando…
The Role of (18)F-FDG-Positron Emission Tomography/Computed Tomography in Staging Primary Breast Cancer
Despite Medicare approving the use of positron emission tomography/computed tomography (PET/CT) in staging primary breast cancer, little evidence is available to support the use of (18)F-FDG-PET/CT for the detection of distant metastases in the initial staging of breast cancer. In this review of the...
Autores principales: | Niikura, Naoki, Ueno, Naoto T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931351/ https://www.ncbi.nlm.nih.gov/pubmed/20842224 |
Ejemplares similares
-
Dual time point (18)F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging ((18)F-FDG PET/CT) in primary breast cancer
por: YAMAGISHI, Yoji, et al.
Publicado: (2019) -
Comparison of (18)F-fluorothymidine Positron Emission Tomography/Computed Tomography and (18)F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer
por: Mori, Mio, et al.
Publicado: (2022) -
18F‐fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of clinically node‐negative non‐small cell lung cancer
por: Takahashi, Yusuke, et al.
Publicado: (2019) -
Role of (18)F-FDG Positron Emission Tomography/Computed Tomography Imaging in Testicular Lymphoma
por: Sahu, Kamal Kant, et al.
Publicado: (2019) -
(18)F-FDG Positron Emission Tomography in Multifocal Pyomyositis
por: Harisankar, C. N. B., et al.
Publicado: (2012)